Early usage of liraglutide with benefits in type 2 diabetes
10.3760/cma.j.issn.1000-6699.2012.04.024
- VernacularTitle:2型糖尿病早期应用利拉鲁肽的益处
- Author:
Changyu PAN
- Publication Type:Journal Article
- Keywords:
Diabetes mellitus,type 2;
Glucagon-like peptide-1;
Liraglutide
- From:
Chinese Journal of Endocrinology and Metabolism
2012;28(4):后插1-后插4
- CountryChina
- Language:Chinese
-
Abstract:
With the progress of type 2 diabetes,there are more challenges for treatment.Traditional medications may not meet type 2 diabetes complicated clinical needs.Glucagon like peptide-1 ( GLP-1 ) has multiple physiological effects.Studies show that the liraglutide as the native GLP-1 analogue provides well glucose control in different stages of type 2 diabetes treatment,as well as β cell protection,body weight decrease and the prevalence of prediabetes reduction.Early usage of liraglutide especially suggests significant benefits,which will be summarized below.
